• 대한방사선치료학회지
• /
• 제21권2호
• /
• pp.83-88
• /
• 2009

목 적: 온 보드영상(OBI)장치를 이용한 콘빔CT는 환자 치료 중 실시간으로 전산화모의치료 영상과 비교하여 환자의 자세 및 표적용적의 움직임과 셋업오차를 확인 할 수 있다. IMRT 시 콘빔CT를 이용해 환자의 자세 및 표적용적의 변화와 움직임을 확인하여 치료계획과의 오차정도를 산출하고, Automatic Match System을 이용하여 위치 보정을 한 후 전자포털영상 장치를 통하여 위치보정의 정확성을 검증하고, IMRT에서 콘빔CT의 유용성과 Automatic Match System의 정확성에 대하여 알아보고 자 한다. 대상 및 방법: 본원에서 치료받은 IMRT 환자 중 두 경부 치료환자 3명, 골반부 치료환자 1명을 대상으로 치료 자세의 변동과 그에 따른 조사용적의 위치변동을 알아보기 위해 선형가속기에 장착된 온 보드 영상 장치를 이용해 콘빔 CT를 촬영하였다. IMRT 전 매 치료 시 마다 콘빔CT를 촬영하여 전산화단층모의치료 영상과 비교하여 좌표별로 치료계획과의 오차값을 확인하고 3D/3D Match의 Automatic Match System을 통하여 치료계획과 일치하도록 이동 보정한 후 전자포털영상 장치를 이용하여 검증, 평가하였다. 결 과: 치료 전 콘빔 CT와 전산화단층모의치료 영상 비교 시 두 경부에서 좌표별 평균오차는 Vertical 0.99 mm, Longitudinal 1.14 mm, Lateral 0.84 mm, Rotation $0.49^o$이고, 골반부의 평균오차는 Vertical 2.78 mm, Longitudinal 2.04 mm, Lateral 4.91 mm, Rotation $1.07^o$로 부위별로 다소 근소한 차이를 보였다. 보정 후 검증에서는 전자포털영상 장치에 의한 영상과 DRR 영상 비교 결과 0.5 mm 이내의 오차로 정확한 보정이 이루어졌음을 알 수 있었다. 결 론: 치료 전 콘빔CT 영상은 환자의 셋업오차와 장기 및 표적의 위치변화를 2차원적 영상의 비교와 달리 하나의 체적으로 재구성된 3차원적 영상으로 비교함으로써 보다 정확하게 위치변화와 표적용적의 변동 등을 측정, 보정하여 정확한 치료를 할 수 있으며, 그 오차 값을 산출하여 비교할 수 있다. 이상의 연구로 보아 콘빔CT는 치료계획과 일치하는 정확한 치료전달과 반복적인 치료재현성에 유용하였으며, 만족스러운 결과를 얻을 수 있었다. 콘빔CT에 의해 향상된 정확도는 복잡한 모양의 표적용적과 급격한 선량분포의 변화가 나타나는 IMRT에서 더욱 필요하며 각 치료 부위별, 치료 목적별로 Match focus에 대한 기준을 연구해야 될 것으로 사료된다.

• 한국의학물리학회지:의학물리
• /
• 제24권3호
• /
• pp.145-153
• /
• 2013

정위적 체부 방사선치료(Stereotactic Body Radiation Therapy, SBRT)는 척추 전이암을 치료하는데 있어서 점점 증가하고 있다. 표적 종양의 급격한 선량 변화와 등선량 분포를 얻기 위해서, 세기조절방사선치료(Intensity-modulated radiation therapy, IMRT)와 체적변조회전치료(Volumetric-modulated arc therapy, VMAT)는 척추 방사선수술에 있어서 필수적인 치료기법이다. 이 연구의 목적은 표적 종양을 위한 International Spine Radiosurgery (ISRC) Consortium의 consensus guideline으로 그려진 표적에 있어서 IMRT와 VMAT의 치료기법을 질적으로 비교하고자 한다. 경부, 흉부, 요추 부위에 종양치료를 받은 3명의 환자를 선택 하였다. 표적 종양은 ISRC의 consensus guideline을 바탕으로 정의 하였다. $T_B$는 vertebral body만 포함하였고, $T_{BPT}$는 vertebral body, pedicle, transverse process를 포함하였다. 그리고 $T_{ST}$는 spinous process와 transverse process를 포함하여 그렸다. Maximum spinal cord선량은 $T_B$, $T_{BPT}$, $T_{ST}$에서 각각 12.46 Gy, 12.17 Gy, 11.36 Gy였고, IMRT, RA1, RA2에서 각각 11.81 Gy, 12.19 Gy, 11.99 Gy였다. 평균 감소(90%~50%) 선량 거리 (mm)는 $T_B$, $T_{BPT}$, $T_{ST}$에서 각각 3.5 mm, 3.3 mm, 3.9 mm였고, IMRT, RA1, RA2에서 각각 3.7 mm, 3.7 mm, 3.3 mm였다. 가장 복잡한 $T_{BPT}$의 경우에서 IMRT, RA1, RA2의 conformity index는 각각 0.621, 0.761, 0.817 이었고, rDHI는 0.755, 0.796, 0.824 였다. IMRT와 VMAT 모두 척추 정위적 방사선수술에서 표적 종양에 급격한 선량 변화와 등선량 분포를 전달하였다. 그러나 표적 종양이 vertebral body, pedicle, transverse process를 포함한다면, IMRT 치료기법은 VMAT 치료기법과 비교해서 conformity index 측면에서 불충분하였다. 그럼에도 불구하고, IMRT 치료기법은 RA1, RA2와 비교해서 대부분의 영역에서 maximum spinal cord 선량을 줄이는데 더 효과적이었다.

• Molecules and Cells
• /
• 제37권9호
• /
• pp.664-671
• /
• 2014

MiR-217 can function as an oncogene or a tumour suppressor gene depending on cell type. However, the function of miR-217 in lung cancer remains unclear to date. This study aims to evaluate the function of miR-217 in lung cancer and investigate its effect on the sensitivity of lung cancer cells to cisplatin. The expression of miR-217 was detected in 100 patients by real-time PCR. The effects of miR-217 overexpression on the proliferation, apoptosis, migration and invasion of SPC-A-1 and A549 cells were investigated. The target gene of miR-217 was predicted by Targetscan online software, screened by dual luciferase reporter gene assay and demonstrated by Western blot. Finally, the effects of miR-217 up-regulation on the sensitivity of A549 cells to cisplatin were determined. The expression of miR-217 was significantly lower in lung cancer tissues than in noncancerous tissues (p < 0.001). The overexpression of miR-217 significantly inhibited the proliferation, migration and invasion as well as promoted the apoptosis of lung cancer cells by targeting KRAS. The up-regulation of miR-217 enhanced the sensitivity of SPC-A-1 and A549 cells to cisplatin. In conclusion, miR-217 suppresses tumour development in lung cancer by targeting KRAS and enhances cell sensitivity to cisplatin. Our results encourage researchers to use cisplatin in combination with miR-217 to treat lung cancer. This regime might lead to low-dose cisplatin application and cisplatin side-effect reduction.

• 대한한의학원전학회지
• /
• 제37권3호
• /
• pp.1-9
• /
• 2024

Objectives : This study aims to clarify the interpretation of the verse "jinyinhuabohetangxia(金銀花薄荷湯下)" in Zhouxuehai(周學海)'s corrective commentary in the Xiaoeryaozhenzhijue(小兒藥證直訣), by examining traditional pediatric texts in relation to the verse. Methods : For each of the three possible interpretations of the instructive phrase for taking herbal formulas-Lonicera flower with peppermint(金銀花+薄荷), gold and silver with peppermint(金銀+薄荷), and gold coin peppermint(金錢薄荷)-applications of these herbs in the various pediatric books were analyzed to determine the most appropriate interpretation. Results & Conclusions : The formulary composition of Liangjingwan(凉驚丸) and Wusewan(五色丸) seems to sufficiently target the pathology of pediatric convulsion(驚癎) and heart malnutrition(心疳). Furthermore, it seems unnecessary to add Lonicera flower(金銀花) to the gastrointestinal fragility(脾胃虛弱) of the malnourished(疳). Some of the herbal formulas in the pediatrics chapter of the Zhengzhizhunsheng(證治准繩) include Lonicera flower(金銀花) to treat only carbuncles(癰腫, 腫毒), while other books do not include it in their formulas. On the other hand, instructions to take water boiled with gold and silver appear in many texts, including the Xiaoeryaozhenzhijue(小兒藥證直訣), and sometimes include gold leaf(金箔) directly in the formula. Descriptions of gold and silver pots with instructions on how to make herbal formulas were found as well, which supports what Zhouxuehai(周學海) commented on the Xiaoeryaozhenzhijue(小兒藥證直訣). Although gold coin peppermint(金錢薄荷) is currently used as Lianqiancao(連錢草) in China, it was difficult to verify its identity as Jinqianbohe(金錢薄荷), which seems to have been recognized as a type of mint in the past. No reported anticonvulsant studies of Lonicera flower(金銀花), gold and silver(金銀), and Lianqiancao(連錢草) were found. Peppermint(薄荷) was ubiquitous in instructions for taking herbal formulas treating pediatric convulsions. Therefore, the instruction to take water boiled with gold and silver, or to take the herbal medicine in water boiled in a gold and silver pot, rather than using Lonicera flower(金銀花), could be considered as an interpretation closer to the original author's intent.

• 한국의학물리학회지:의학물리
• /
• 제24권3호
• /
• pp.154-161
• /
• 2013

본 연구는 총 10명의 전립선 암 환자를 대상으로 세기조절방사선치료(IMRT), 균일스캐닝양성자치료(USPT), 그리고 세기조절양성자치료(IMPT)기술을 이용한 치료계획의 결과를 비교, 평가 하였다. 각 치료 계획은 타깃 체적의 95%에 70 Gy가 28회 분할 조사되도록 하였으며 세기조절방사선치료(IMRT)에서는 step-and-shoot 기법을 이용하여 총 7개의 빔을 사용하여 방사선을 조사하였고, 균일세기양성자치료(USPT)와 세기조절양성자치료(IMPT)에서는 동일한 방사선 가중치의 측방향대향조사면(lateral opposing field)를 사용하여 타깃에 처방선량이 전달되도록 하였다. 한편, 세기조절양성자치료(IMPT)의 최적화를 위해 IMRT치료와 유사한 Inverse planning을 수행하였다. 결과 비교를 위해 타깃의 균질성지수(homogeneity index) 및 동형지수(conformity index)와 정상조직의 정상조직합병증확률(NTCP)을 계산하였다. 비록 치료기법간에 균질성지수(homogeneity index), 동형지수(conformity index)차이가 크지 않았지만, 직장의 경우 각 세기조절방사선치료(IMRT), 균일스캐닝 양성자치료(USPT) 및 세기조절양성자치료(IMPT)에서 2.233, 3.326 및 1.707로 계산되었다. 또한 방광의 정상조직합병증확률(NTCP)는 0.008, 0.003, 및 0.002를 나타내었다. 직장과 방광의 NTCP 값이 IMPT을 사용할 때 유의하게 낮은 값을 보이는 것을 확인하였다. 본 연구를 통해 전립선 암의 방사선 치료 시 세기조절방사선치료(IMRT)보다 양성자를 이용한 방사선 치료, 특히 최적화된 세기조절양성자치료(IMPT)가 치료 효과를 높일 수 있는 치료계획이 될 수 있음을 확인할 수 있었다.

• 해양환경안전학회:학술대회논문집
• /
• 해양환경안전학회 2003년도 춘계학술발표회
• /
• pp.41-58
• /
• 2003

A recent trend of global shipping industry adopting Port State Control (PSC) system is recognized as a proficient mechanism in preventing costal traffic accident and protecting marine environment. Disadvantages of Korean shipping companies in PSC inspection are unavoidable as Tokyo MOU imposed priority listed flag to Korea. Having stated above, appropriate research and prompt preparation in compliance with current PSC requirements for the Korean shipping companies have become an immediate need. The objectives of this study are : First, to review in understanding of PSC in overall and foundation of enforcement. Second. to study interaction of international treaties regarding PSC. Third, to compare practical compliance among the countries and to open up a case study on Korean shipping companies in adopting PSC. Last, to suggest direction to the Korean shipping companies the most proficient way in compliance with the current Tokyo MOU requirement. Korean flagged vessels have become prioritized target in PSC inspection as Tokyo MOU imposed priority listed flag to Korea due to high detention rate of its fleet. Disadvantage of a priority listed flag is a burden in its proficient fleet operation. This study suggests solutions to the disadvantages as below. : 1) Change shore management system, and provide continuous & quality education to crew members 2) Form a network in sharing PSC information among the Korean shipping companies 3) Form a centralized function in which government, Korean Shipping register and shipowners can treat problems in a prompt manner.

• 통상정보연구
• /
• 제13권4호
• /
• pp.399-410
• /
• 2011

전통적으로 자국 산업의 이익보호를 위해 관세는 널리 사용되어 왔다. 개발도상의 단계에 있는 나라들은 자국의 유치산업을 보호할 목적으로 관세를 사용하는 반면, 선진국들은 자국의 상품이 타국의 시장에 진출할 수 있도록 타국을 압박하는 수단으로 사용되는 경우가 많다. 본 논문에서는 선진국이 자국의 특정 수출품을 개발도상국 시장에 일정한 비율 이상 진출시키기 위해 개발도상국의 제3의 생산품에 관세를 부과하겠다는 위협을 하는 경우 그 경제적 효과를 간단한 게임이론 모형을 통해 살펴본다. 만약 관세가 부과된 제3의 생산품이 주력 수출품인 경우 개발도상국 정부는-주력 수출품 생산자들의 로비 등을 통해-문제가 된 상품에 일정한 제재를 부과함으로써 선진국과의 마찰을 자발적으로 해소하려는 유인을 갖게 됨을 보인다. 이러한 결과는 최근 FTA로 대변되는 양자 간 무역협정의 체결에서 나타나는 산업 간 이해득실의 차이를 개별 산업의 협상력 차이로 설명할 수 있다는 의미를 지닌다.

• 대한핵의학회지
• /
• 제36권1호
• /
• pp.74-79
• /
• 2002

In addition to the well-established use of positron emission tomography (PET) in clinical oncology, novel roles for PET are rapidly emerging in the field of gene therapy. Methods for controlled gene delivery to living bodies, made available through advances in molecular biology, are currently being employed in animals for research purposes and in humans to treat diseases such as cancer. Although gene therapy is still in its early developmental stage, it is perceived that many serious illnesses could be treated successfully by the use of therapeutic gene delivery. A major challenge for the widespread use of human gene therapy is to achieve a controlled and effective delivery of foreign genes to target cells and subsequently, adequate levels of expression. As such, the availability of noninvasive imaging methods to accurately assess the location, duration, and level of transgene expression is critical for optimizing gene therapy strategies. Current endeavors to achieve this goal include methods that utilize magnetic resonance imaging, optical imaging, and nuclear imaging techniques. As for PET, reporter systems that utilize genes encoding enzymes that accumulate positron labeled substrates and those transcribing surface receptors that bind specific positron labeled ligands have been successfully developed. More recent advances in this area include improved reporter gene constructs and radiotracers, introduction of potential strategies to monitor endogenous gene expression, and human pilot studies evaluating the distribution and safety of reporter PET tracers. The remarkably rapid progress occurring in gene imaging technology indicates its importance and wide range of application. As such, gene imaging is likely to become a major and exciting new area for future application of PET technology.

• Membrane and Water Treatment
• /
• 제11권4호
• /
• pp.257-274
• /
• 2020

There are many previous review articles are available to summarize either the characterization methods of effluent organic matter (EfOM) or the individual control treatment options. However, there has been no attempt made to compare in parallel the physicochemical treatment options that target the removal of EfOM from biological treatments. This review deals with the recent progress on the characterization of EfOM and the novel technologies developed for EfOM treatment. Based on the publications after 2010, the advantages and the limitations of several popularly used analytical tools are discussed for EfOM characterization, which include UV-visible and fluorescence spectroscopy, Fourier transform infrared spectroscopy (FTIR), size exclusion chromatography (SEC), and Fourier transform-ion cyclotron resonance-mass spectrometry (FT-ICR-MS). It is a recent trend to combine an SEC system with various types of detectors, because it can successfully track the chemical/functional composition of EfOM, which varies across a continuum of different molecular sizes. FT-ICR-MS is the most powerful tool to detect EfOM at molecular levels. However, it is noted that this method has rarely been utilized to understand the changes of EfOM in pre-treatment or post-treatment systems. Although membrane filtration is still the preferred method to treat EfOM before its discharge due to its high separation selectivity, the minimum requirements for additional chemicals, the ease of scaling up, and the continuous operation, recent advances in ion exchange and advanced oxidation processes are greatly noteworthy. Recent progress in the non-membrane technologies, which are based on novel materials, are expected to enhance the removal efficiency of EfOM and even make it feasible to selectively remove undesirable fractions/compounds from bulk EfOM.

• 지질동맥경화학회지
• /
• 제7권2호
• /
• pp.77-87
• /
• 2018

Lowering serum low-density lipoprotein cholesterol (LDL-C) is the mainstay for reduction of risk of cardiovascular disease (CVD), the second most common cause of death in Korea. The 2015 Korean guidelines for management of dyslipidemia strongly recommend the use of statins in patients at risk of CVD. Statin therapy, which is the gold standard for CVD, reduces LDL-C level by 40% to 60% and is generally well tolerated. However, many patients are intolerant to statins and discontinue therapy or become nonadherent to therapy because of actual/perceived side effects. The most common of these side effects is the statin-associated muscle symptom (SAMS). Discontinuation and repetitive re-challenge with statins can help identify SAMS. If serum creatinine kinase level is more than 10 times the upper limit of normal, statin therapy must be stopped immediately, and the physician should identify possible causes including rhabdomyolysis and treat appropriately. In other patients, it might help to switch to a less potent statin or to use statins at intermittent non-daily dosing. To achieve target LDL-C level, non-statin lipid-lowering therapies such as dietary modifications, ezetimibe, and bile acid sequestrants may be added. Several new drugs have recently been approved for lowering LDL-C level. Alirocumab and evolocumab are monoclonal antibodies that inhibit proprotein convertase subtilisin/kexin type 9, and both drugs cause large reductions in LDL-C, similar to statins. Lomitapide and mipomersen are orphan drugs used as adjuncts to other lipid-lowering therapies in patients with homozygous familial hypercholesterolemia.